HEMESIGHT Trademark

Trademark Overview


On Tuesday, December 15, 2020, a trademark application was filed for HEMESIGHT with the United States Patent and Trademark Office. The USPTO has given the HEMESIGHT trademark a serial number of 79305516. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The HEMESIGHT trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Diagnostic preparations for medical purposes for diagnosing and treating cancer through genetic testing; diagnostic reagents for medical use in diagnosing cancer

Providing medical information in the field of genetic and sequencing testing for the diagnosis and treatment of cancer; medical diagnostic services in the nature of performing diagnosis of disease in the field of cancer diagnostics; medical testing for diagnostic or treatment purposes, namely, genetic testing and sequencing tests for diagnosis and treatment of cancer
hemesight

General Information


Serial Number79305516
Word MarkHEMESIGHT
Filing DateTuesday, December 15, 2020
Status700 - REGISTERED
Status DateTuesday, May 24, 2022
Registration Number6733728
Registration DateTuesday, May 24, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 8, 2022

Trademark Statements


Goods and ServicesDiagnostic preparations for medical purposes for diagnosing and treating cancer through genetic testing; diagnostic reagents for medical use in diagnosing cancer
Pseudo MarkHEME SIGHT
Goods and ServicesProviding medical information in the field of genetic and sequencing testing for the diagnosis and treatment of cancer; medical diagnostic services in the nature of performing diagnosis of disease in the field of cancer diagnostics; medical testing for diagnostic or treatment purposes, namely, genetic testing and sequencing tests for diagnosis and treatment of cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 12, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 12, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressJP

Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJP

Trademark Events


Event DateEvent Description
Monday, March 13, 2023NEW REPRESENTATIVE AT IB RECEIVED
Sunday, October 2, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, September 8, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 8, 2022FINAL DISPOSITION PROCESSED
Wednesday, August 24, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, May 24, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 24, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, March 8, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2022PUBLISHED FOR OPPOSITION
Monday, March 7, 2022NOTIFICATION PROCESSED BY IB
Wednesday, February 16, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 16, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 16, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 28, 2022EXAMINER'S AMENDMENT ENTERED
Friday, January 28, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, January 28, 2022EXAMINERS AMENDMENT E-MAILED
Friday, January 28, 2022EXAMINERS AMENDMENT -WRITTEN
Friday, December 17, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 16, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 16, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 5, 2021REFUSAL PROCESSED BY IB
Wednesday, June 16, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, June 16, 2021REFUSAL PROCESSED BY MPU
Friday, June 11, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, June 10, 2021NON-FINAL ACTION WRITTEN
Wednesday, June 2, 2021ASSIGNED TO EXAMINER
Tuesday, March 16, 2021APPLICATION FILING RECEIPT MAILED
Friday, March 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 11, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, March 4, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB